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Background: The effectiveness of weight loss therapies is commonly measured using body mass index and other
obesity-related variables. Although these data are often stored in electronic health records (EHRs) and potentially
very accessible, few studies on obesity and weight loss have used data derived from EHRs. We developed processes
for obtaining data from the EHR in order to construct a database on patients undergoing Roux-en-Y gastric bypass
(RYGB) surgery.
Methods: Clinical data obtained as part of standard of care in a bariatric surgery program at an integrated health
delivery system were extracted from the EHR and deposited into a data warehouse. Data files were extracted,
cleaned, and stored in research datasets. To illustrate the utility of the data, Kaplan-Meier analysis was used to
estimate length of post-operative follow-up.
Results: Demographic, laboratory, medication, co-morbidity, and survey data were obtained from 2028 patients
who had undergone RYGB at the same institution since 2004. Pre-and post-operative diagnostic and prescribing
information were available on all patients, while survey laboratory data were available on a majority of patients. The
number of patients with post-operative laboratory test results varied by test. Based on Kaplan-Meier estimates, over
74% of patients had post-operative weight data available at 4 years.
Conclusion: A variety of EHR-derived data related to obesity can be efficiently obtained and used to study
important outcomes following RYGB.
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Obesity is a multi-factorial disease that has reached epi-
demic proportions in the US, with about two thirds of
adult Americans overweight (body mass index [BMI]
> 25 kg/m2), one third obese (BMI >30 kg/m2), and
about 5% with class III levels of obesity (BMI> 40 kg/
m2) [1]. Obesity is associated with increased risk for a
variety of co-morbidities, higher lifetime health care
expenditures, and a greater risk for mortality [2]. In-
creasing BMI is associated with further increases in dis-
ease burden and risk of mortality [3] and the
prevalences of both class III (BMI> 40 kg/m2) and super
(i.e., BMI >50 kg/m2) obesity are rising faster than other* Correspondence: gsgerhard@geisinger.edu
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reproduction in any medium, provided the orclasses of obesity [4]. Dietary modification and physical
activity are effective at decreasing obesity-related disease
risk and severity [5], although only modest weight loss is
usually achieved and few individuals are able to maintain
weight loss over long periods. In contrast, Roux-en-Y
gastric bypass (RYGB) surgery commonly results in a
more substantial and sustained weight loss, and has thus
emerged as a more effective therapy for long-term
weight loss in morbidly obese patients [6], and more re-
cently, as a surgical therapy for type 2 diabetes [7]. How-
ever, the degree of weight loss with RYGB is variable
[8,9] and the factors determining long-term success are
not known. The effect of RYGB of various clinical out-
comes is also not well characterized.
To conduct research on RYGB outcomes, significant
resources are required for the long-term follow-up of
patients as well as for clinical characterization. Economictd This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Flow diagram of data used to generate research
database.
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clinical infrastructure. One such resource that has only
recently been exploited for research is the electronic
health record (EHR). Body mass index, calculated from
height and weight, is perhaps the most commonly used
measure of obesity and is often measured during clinical
encounters and entered into EHRs. A large number of
other variables, such as laboratory test results, the pres-
ence of co-morbid conditions, and medication use are
also often recorded in EHRs. The potential availability of
such data suggests that EHRs may be a rich resource for
RYGB and obesity research.
We have developed a research database within the
context of a Weight Management Clinic at a large inte-
grated health system through utilization of an EHR fed
data warehouse. A large number of clinical variables on
patients undergoing RYGB surgery were extracted and
assembled into research datasets. To illustrate the poten-
tial utility of the data, we estimated the length of post-
operative follow-up after RYGB surgery. The efficient
electronic acquisition of these data serves as a new para-
digm for RYGB and obesity research.
Methods
Patients
All patients who were enrolled in the bariatric surgery
program in the Center for Nutrition and Weight Man-
agement at Geisinger Clinic were offered participation in
an ongoing research program in obesity using clinical
data accessed through the electronic health record that
was approved by the Geisinger Clinic Institutional Re-
view Board. For this study, a total of 2028 patients who
underwent RYGB gastric bypass surgery from 01/01/
2004 through 07/02/2010 were included in the database.
The bariatric surgery program consisted of a 6 to
12 month pre-operative assessment and preparation
period that included a diet-induced weight loss target of
10% of body weight. Patients were followed at approxi-
mately 1, 3, 5, and 12 months following RYGB surgery
and every 12 months thereafter. All clinical data were
entered into the EpicCareW EHR (Verona, WI). The
EpicCareW EHR integrates information from a variety of
sources into a common interoperable database that
includes patient demographics, vitals, clinical measures,
problem list (based on ICD-9 codes), medical history,
medication history, personal and family histories,
encounters (e.g. office visits, hospitalizations, nurse
encounters, telephone inquiries and specialty consulta-
tions), orders (e.g. labs, medications, imaging and proce-
dures), appointments, digital imaging (e.g. MRI, CT, X-
ray, medical photography), results (e.g. procedure
reports, lab results, pathology reports), and billing and
claims databases (detailed financial transactions asso-
ciated with each clinical encounter). All data exceptlaboratory results, which were fed directly to the EHR by
the laboratory information system, were entered at the
point-of-care including age, sex, height, and weight, life-
style factors (e.g., smoking, alcohol, etc.), clinical mea-
sures (e.g., blood pressure), all orders (i.e., lab requests,
prescriptions, imaging, and procedures) which require at
least one indication (i.e., ICD-9 code), active use of all
medications, and all co-morbidities. The schema for data
acquisition is shown in Figure 1.
EHR and data warehouse
Data were extracted from an EHR-fed comprehensive
enterprise-level data warehouse, the Clinical Decision
Intelligence System (CDIS), which is partially comprised
of the EHR. EpicCare EHR modules feeding data to
CDIS included ambulatory, inpatient, surgery, emer-
gency department, e-prescribing, computerized phys-
ician order entry, pharmacy, registration, scheduling,
and reporting, thus data derived from clinical care pro-
vided not only at the Weight Management Clinic was
included but also from other sites within the Geisinger
Health System, including over 40 primary care sites and
other specialty clinics. Other source systems, including
financial decision support, insurance claims, patient sat-
isfaction, and high-use third-party reference datasets
were also deposited into CDIS.
CDIS was built on the IBM InfoSphere (DB2W) Ware-
house 9 platform. The input data were extracted from
several sources, predominantly the EpicCare EHR, and
were transformed by selecting as needed by data type,
and then loaded into the warehouse software by over-
writing existing data with cumulative information. Clar-
ity, an Oracle relational database with a data schema
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data out of EPIC using the extract-transform-load process.
Extracts from Clarity consisted of preselected tables and
data elements. These selected tables were transferred and
loaded into CDIS using the IBM DB2 database software.
The load into CDIS was then a data replication.
An analytics engine was built around the IBM
Balanced WarehouseW for AIXW technology that enabled
data mining, text analytics, reporting, and data analysis.
In addition to the IBM InfoSphere Warehouse Informa-
tion Server software and analytics engine, a reporting
tool from IBM Business Partner Business Objects was
used to provide user-friendly query and analysis, and
data integration interface. The data in CDIS was stored
as a relational database at the most granular level to
allow for an effectively unlimited number of reporting,
analysis, and application outputs. A copy of the CDIS
data warehouse was stored on a separate server that
allowed for direct data extraction into SAS using a
Microsoft (Bellevue, WA) Open Database Connectivity
(ODBC) interface. For example, the RYGB research
datasets are refreshed on a regular basis (i.e. minimum
every 3 months or sooner as needed). CDIS is updated
on a nightly basis from EpicCare and less frequently
from the other source systems (e.g., monthly).
Data extracted
The extracted data for the RYGB database study include
the following:
 Demographics: date of birth, gender, race, death
status, and death date (one row per patient)
 Problem list: current and historical list of medical
co-morbidities maintained and entered by treating
providers (one row per diagnosis code per unit time)
 Outpatient office visit encounters: date of encounter,
diagnoses assigned on that encounter, clinic that
encounter took place, measurements taken at that
encounter (e.g. weight, height, blood pressure, pulse,
temperature) (one row per encounter)
 Inpatient admissions: admit and discharge dates,
diagnosis codes, and name of admitting clinic (one
row per admission).
 Medication list: current and historical list of active
medications maintained and entered by treating
providers (one row per diagnosis code per unit time)
 Medication prescription orders: date, name of
medication, associated diagnosis for medication
order, name of clinic that ordered medication (one
row per medication order)
 Procedures: all inpatient and outpatient medical
procedures including date, procedure code, and
name of clinic that conducted procedure (one row
per procedure) Laboratory test results: all laboratory results
including dates, lab type, lab name, and lab resulted
value (one row per laboratory result)
 Social history: historical and current alcohol and
smoking history that are maintained and entered by
treating providers (one row for each change in
status over time)
 RYGB flowsheets: data collection tools that are
entered for specific encounter types (e.g. RYGB
surgical evaluation visit) that included but are not
limited to dietician evaluation status, resting energy
expenditure, surgeon, and weight loss goals
 Surveys: item responses to each survey question and
date of survey completion
Most of the data were obtained as coded fields except
for waist circumference, dietician evaluation status,
psychologist evaluation status, resting energy expend-
iture, surgeon, tobacco and alcohol use at time of pre-
surgical visit, and weight loss goals. These were free text
but were recorded with pre-defined structures/guidelines
that enabled consistent retrieval of the data. The extracted
data were stored as SAS dataset files. Supporting data
were gathered through departmental tracking databases
(including landmark dates such as date of consent, date of
initial visit, date of surgery, etc.) and through chart review
(e.g. to validate the date and type of surgery).
Survey data acquisition
At each new patient visit, the following surveys were
obtained: Beck Depression Inventory (BDI) [10], Family
Emotional Involvement and Criticism Scale (FEICS)
[11], Impact Of Weight On Quality Of Life-Lite
(IWQOL) [12], Weight Loss Readiness Test [13], Sleep
Scale for Medical Outcomes [14], Work Limitations
[15], and Questionnaire on Eating and Weight Patterns
(QEWP) [16]. The Beck Depression Inventory and the
Impact Of Weight On Quality of Life-Lite were initiated
near the start of the program (i.e. patients with surgeries
occurring since 10/01/2004) and were also administered
during the post-operative period. The remaining surveys
were administered to patients since 01/10/2006 but only
in the pre-operative period.
Surveys were self-administered using one of two col-
lection methods. The most common method was a
paper survey formatted for electronic scanning using op-
tical character recognition (OCR). These surveys were
collected, batched for scanning using Kofax Capture
software (Irvine, CA) and OCR processing using Sun-
gard version 5.0 (Birmingham, AL), exported into delim-
ited text files, and stored in SAS (Statistical Analysis
System version 9.2, Cary, NC) datasets. The second
method was an internet based EHR patient portal,
MyGeisinger, allowing some patients to complete the
Table 1 Demographic data (n=2028)
Gender
Male, n (%) 385 (19%)
Female, n (%) 1643 (81%)
Age
Median [range] 46 [18, 72]
Race
White/Caucasian, n (%) 1960 (97%)
Black, n (%) 44 (2%)
Other, n (%) 24 (1%)
Smoking
Current, n (%) 204 (11%)
Quit, n (%) 711 (38%)
Never, n (%) 948 (51%)
Not known, n (%) 165 (8%)
Any alcohol use
Yes, n (%) 729 (41%)
No, n (%) 1029 (59%)
Not known, n (%) 270 (13%)
Height (inches)
Mean (SD) 65.5 (3.4)
Median [range] 65.0 [54.8, 78.0]
Weight (pounds)
Mean (SD) 303 (64)
Median [range] 292 [180, 614]
BMI (kg/m2)
Mean (SD) 49.6 (8.8)
Median [range] 47.9 [32.5, 94.3]
Waist circumference
Mean (SD) 53.5 (6.5)
Median [range] 52.8 [39.0, 76.0]
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the EHR and were available in the data warehouse
described below. All survey responses were collected,
imported into SAS, scored per validated algorithms (when
applicable), and stored in SAS datasets.
Dataset creation and cleaning
Datasets containing all of the clinical and survey data
were created in SAS format, each containing a patient
identifier used to link patient data between sources. SAS
was used to manipulate, clean, and merge data for sum-
mary descriptive information and complex statistical
analyses. Data cleaning algorithms were created to iden-
tify obvious errors and implausible values. An example
of the algorithm used for weight and BMI is described
below.
Clinically implausible values were identified and
flagged for removal (e.g. weight <50 lbs. or weight
>1000 lbs.). To identify other obvious data entry errors,
i.e. those that fell within clinically acceptable ranges but
were likely erroneous when compared to the patient’s
other weight measures, a series of simple linear regres-
sion models (pre-surgery, 0–1 year post RYGB surgery,
and 1+ years post RYGB surgery) were used. Due to the
large number of weight measures for each patient, the
linear models were run independently for each subject,
and the distribution of residuals across all subjects was
evaluated. Weight measures with residuals in the ex-
treme tails of the distribution, i.e., +/− 5 standard devia-
tions were flagged for consideration for exclusion. The
flagged values were then manually evaluated and data
entry errors were removed as indicated. BMI was calcu-
lated for all weight measures using the height recorded
at the initial Weight management clinic visit. The pres-
ence of clinically implausible BMI values was investi-
gated (e.g. BMI< 15 kg/m2 or BMI> 100 kg/m2) but
none were found due to the initial weight cleaning
algorithm.
Statistical analysis
A descriptive summary was completed using means,
standard deviation, and percentages, as appropriate.
Kaplan-Meier curves were used to evaluate time until
loss of follow-up. Patients were defined as lost to follow-
up when they had a 24 month period without a weight
measurement in the EHR. The date of surgery was used
as the anchor point for the Kaplan Meier analysis. For
those in active follow-up, the censor time was calculated
by using date of last BMI measurement. The Kaplan
Meier curves were stratified by initial BMI (35.0–39.9,
40.0–49.9, and 50.0+ kg/m2). The log rank test was used
to evaluate whether length of follow-up was associated
with initial BMI, year of surgery, surgeon, or surgical ap-
proach (open versus laparoscopic).Results
All patients enrolled in the Geisinger Bariatric Surgery
clinical program are offered participation in the ongoing
obesity research program. The results presented below
were obtained from 2028 patients who had completed
RYGB surgery between January 1, 2004 and July 2, 2010.
The overall consent rate for this group was greater than
90%. The program continues to accrue patients at a
similar rate.
Demographic and weight data
The population was 81% female, 97% Caucasian ances-
try, with a median age of 46 years (Table 1). Smoking
and alcohol use data were not available on 8% and 13%
of patients respectively, with a majority of the patients
classified as either non-smokers or non-drinkers. Height,
Table 3 Use of common medication subclasses (N=2028)
Medication subclass Frequency
Biguanides 817 (40%)
Proton Pump Inhibitors 765 (38%)
NSAIDs 765 (38%)
SSRIs 698 (34%)
HMG CoA Reductase Inhibitors 661 (33%)
Opioid Combinations 567 (28%)
Salicylates 533 (26%)
ACE Inhibitors 532 (26%)
Beta Blockers Cardio-Selective 516 (25%)
Sympathomimetics 503 (25%)
Loop Diuretics 452 (22%)
Thyroid Hormones 407 (20%)
Insulin 298 (15%)
Thiazides and Thiazide-Like Diuretics 295 (15%)
Antihypertensive Combinations 263 (13%)
Insulin Sensitizing Agents 258 (13%)
Sulfonylureas 253 (13%)
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management clinic visits. A median height of 65 cm and
median weight of 292 pounds corresponded to a median
BMI of 47.9 kg/m2. Median waist circumference was
52.8 cm at the initial clinical evaluation obtained on over
80% of patients. A total of 58 weight measurements
(0.1% of 39,823 weight measures) from 42 patients (2%
of 2028 patients) were classified as clinically implausible
or data entry errors and were removed from the analysis.
Co-morbid conditions
ICD-9 codes assigned during the pre-RYGB surgery
period were used to identify the presence of co-morbid
conditions. A total of 2067 unique 5 digit ICD-9 codes
were found (Additional file 1: Table S1), with 177 occur-
ring in at least 10% of the patients. Hypertension, hyper-
cholesterolemia, diabetes, sleep disturbances (primarily
sleep apnea), and depression were found in over one-
third of the patients (Table 2). Diseases of the esophagus
(primarily gastro-esophageal reflux disease or GERD),
osteoarthrosis, hypothyroidism, and asthma were found
in at least 15% of patients. The median number of ICD-
9 diagnoses per patient was 12 with many patients hav-
ing 20 or more (Additional file 1: Figure S1).
Medication use
Patient medication use prior to surgery was obtained
from the active medication list. A total of 349 medica-
tion subclasses were ordered (Additional file 1: Table
S2), with 177 occurring in at least 10% of the patients.
Biguanides (primarily metformin), proton pump inhibi-
tors, NSAIDs, SSRIs, and HMG CoA Reductase Inhibi-
tors were prescribed for at least one-third of the patients
(Table 3). Opioid combinations, salicylates, ACE inhibi-
tors, beta blockers cardio-selective, sympathomimetics,
loop diuretics, thyroid hormones, insulin, thiazides and
thiazide-like diuretics were prescribed for at least 15% of
the patients. The median number of medications per pa-
tient was 11 with polypharmacy of more than 20 medi-





Sleep disturbances 737 (36%)
Depression 717 (35%)
Diseases of esophagus 637 (31%)
Osteoarthrosis 534 (26%)
Hypothyroidism 369 (18%)
Asthma 314 (15%)Laboratory results
A total of 873 different laboratory results were obtained
in the pre-surgery period (Additional file 1: Table S3),
with 190 occurring in at least 10% of the patients. Results
obtained in the pre-RYGB period for the following la-
boratory tests were found for at least 95% of the patients:
glucose, creatinine, potassium, blood urea nitrogen (bun),
calcium, chloride, CO2, sodium, hematocrit (hct),
hemoglobin (hgb), mean cell hemoglobin (mch), mean
cell hemoglobin concentration (mchc), mean cell volume
(mcv), platelet count, red blood cell count (rbc), red cell
distribution width (rdw), white blood cell count (wbc),
estimated glomeruler filtration rate (gfr estimated), albu-
min, alanine aminotransferase (alt), total protein (pro-
tein), alkaline phosphatase, aspartate aminotransferase
(ast), total bilirubin, mean platelet volume (mpv), total
cholesterol, hdl cholesterol (hdl), triglycerides, choles-
terol/hdl ratio, low density lipoprotein (ldl calculated),
thyroid stimulating hormone (TSH), hemoglobin A1c,
and insulin. Other test results were found for at least half
of the patients including ferritin, iron, iron binding cap-
acity, transferrin saturation, anion gap, folic acid, intact
parathyroid hormone (PTH), 25 oh vitamin D2 (25 oh
D2), 25 oh vitamin D3 (25 oh D3), total vitamin D, urine
creatinine, urine protein, urine protein/creatinine ratio,
and zinc. Many of the most commonly ordered tests
(results in Additional file 1: Table S4) were also ordered
following surgery (Table 4), although the post-RYGB
period is characterized by clinical need for disease-specific
monitoring.























Alkaline phosphate 99% 69%
Total Bilirubin 99% 69%










Iron Binding Capacity 88% 48%
Transferrin Saturation 88% 45%
Anion Gap 87% 91%
PTH 83% 71%
Folic Acid 68% 23%
Figure 2 Kaplan-Meier curves of length of follow-up (N= 2028).
The plots are based upon a sample size of 174 patients with 3255
weight measurements for initial BMI of 35–39 kg/m2, 1032 patients
with 20,284 weight measurements for initial BMI of 40–49 kg/m2,
and 822 patients with 16,226 weight measurements for BMI of 50+
kg/m2.
Wood et al. BMC Medical Informatics and Decision Making 2012, 12:45 Page 6 of 8
http://www.biomedcentral.com/1472-6947/12/45Survey data
A total of 7 surveys were obtained at some point during
the pre- and post-operative periods (Additional file 1:
Table S5). When limiting to the subset of patients that
were eligible to complete the survey, there were high re-
sponse rates for the Beck Depression Inventory (BDI,79% completion), Family Emotional Involvement and
Criticism Scale (FEICS, 80% completion), and Impact Of
Weight On Quality Of Life-Lite (IWQOL, 70% comple-
tion) prior to surgery. The response rates were lower for
the remaining surveys, with a 42% completion rate for
Weight Loss Readiness, the Sleep Scale, and the work
limitations surveys. When limiting to those that were at
least one-year post surgery and completed a survey prior
to surgery, the number of surveys obtained in the post-
operative period was 33% for the BDI and 23% for the
IWQOL.
Length of follow-up
The amount of time a patient is followed after a weight
loss intervention is extremely important since the per-
centage of patients that experience weight gain recidiv-
ism is high. We used date of surgery and dates
associated with follow-up BMI measurements to calcu-
late the percentage of patients lost to follow-up over
time using Kaplan-Meier curves (Figure 2 and Add-
itional file 1: Table S6). Because patients with lower
degrees of obesity may achieve desired weight loss goals
sooner than patients with more extreme levels of obesity
[17,18], we stratified patients into three BMI ranges, 35–
39, 40–49, and 50+ kg/m2. As can be seen in Figure 2,
patients in the 35–39 kg/m2 range had similar or higher
rates of follow-up data until 48 months when they had a
77% follow-up rate versus 79% and 74% for the other
two groups (log rank p-value = 0.077), although the sam-
ple size is small for the lighter patients. At 1 year all
three BMI groups had 92% or greater rates of patients
with follow-up data, and at both 24 and 36 months only
patients in the highest BMI category were less than 80%
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per year over the course of the follow-up period.
We found no significant differences among year of
surgery in length of follow-up for 2004, 2005, 2006, and
2007 (log-rank p-value = 0.262). The effect of surgeon on
follow-up was also evaluated. There were five primary
surgeons that accounted for 96% of the surgeries, with 2
of the 5 who accounted for 66% of the surgeries. These
two surgeons were compared with each other and with
the other surgeons as a single group. No significant dif-
ference was found in length of follow-up (p = 0.130). We
also analyzed the type of surgical approach (open versus
laparoscopic), which was also not related to length of
follow-up (p = 0.123).
Discussion
The EHR is a longitudinal electronic record of patient
health information generated by clinical encounters in a
variety of care delivery settings and includes patient
demographics, progress notes, problem lists, medica-
tions, vital signs, past medical history, immunizations,
laboratory data, and radiology reports. EHRs make use
of relational database structures and utilities to access
and display data that facilitate medical care and clinical
decision-making, substituting for traditional paper-based
“charts”. EHRs may also help address the long-standing
problem of the long lag time that exists before evidence-
based medical knowledge is used in clinical care [19]. In
addition, the EHR is a robust source of data that can be
exploited for research. It provides a means to characterize
patients through exploiting existing clinical data, rather
than re-capitulating such data via research activities.
In research protocols, physical measures such as
height and weight are generally collected by research
assistants trained in specific protocols. The tools for
those measurements are typically calibrated instruments
to reduce error. In contrast, clinical measurements that
are recorded in the EHR may be taken by a variety of
health care professionals whose procedures may be less
stringent, and with equipment that may differ by loca-
tion. For example, weights may be fully clothed or
gowned; heights may be with shoes or without. Some of
this type of error can be mitigated by large sample sizes,
but some systematic errors cannot. If, for example, the
majority of heights are measured with shoes, BMI calcu-
lations will be systematically biased downwards. In this
study, key height and weight data were extracted from
the EHR from measurements obtained in the Weight
Management clinic in which a research-like standardized
process using calibrated instruments was performed by
trained personnel in the same clinic. This standardization
also improves the rate of measurement of height, which
is measured less frequently than the measurement of
weight in EHRs [20].Data on medication usage and co-morbidities may
also present potential problems when extracting from
EHRs. We used medication reconciliation and not phys-
ician medication orders, sometimes used as a proxy for
medication usage. However, not all filled prescriptions
will be used by patients. International Classification of
Diseases, ninth revision, (ICD-9) codes, which are used
for billing, insurance, and documentation in EHRs, as
well as for tabulation of clinical statistics and quality
analyses, were used as surrogates for the presence of co-
morbid conditions. We did not attempt to document
the accuracy of individual ICD-9 codes using supporting
data such as laboratory results or medication orders.
However, the percentages of patients assigned specific
ICD-9 codes was similar to the percentage of patients
prescribed corresponding medications for a number of
major disorders including diabetes and biguanides, de-
pression and SSRIs, and osteoarthosis and NSAIDs. Less
closely correlated were hypertension and hypertension
medications likely because of the use of tailored poly-
pharmacy to treat individual patients. In addition, the
percentage of patients prescribed proton pump inhibi-
tors was higher than the number with GERD likely be-
cause of prescribing for other gastrointestinal disorders.
Laboratory data are among the most robust data
available from EHRs. We were able to extract a large
number of laboratory variables on most patients. Two
major reasons for why patients lacked data were that
the tests were either never ordered or were obtained at
an outside laboratory and the results transmitted in
non-electronic form, i.e. paper or scanned portable
document format (pdf ) copy. This contrasts with sur-
vey data in which surveys were offered by providers to
each patient, whether in scannable paper format or
through on-line access. Since they were not “pre-
scribed” through formal physician order entry, the rela-
tive rate of return of this data was less than other types
of data domains. Nevertheless, substantial numbers of
several survey instruments were obtained.
Despite the presence of clinical data in EHRs that are
readily accessed by providers on individual patients,
such data can be logistically difficult to extract for re-
search use. Some research groups have been develop-
ing natural language processing approaches to obesity-
related EHR data [21-23]. We used a data warehouse
that mirrored the EHR and greatly facilitated practical
access to data. Other obesity research studies have uti-
lized data warehouses [24]. The Veterans Health Ad-
ministration stores height and weight measurements
that have been entered into the EHR in the national
Corporate Data Warehouse (CDW). Similar to the Gei-
singer CDIS data warehouse, the CDW was developed
to allow access to data and tools for several purposes
including research. Although weight, height and other
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not yet contain data on laboratory measures, proce-
dures, and diagnoses.
Consensus guidelines have been recommended for de-
termining weight loss following bariatric surgery using
operative weight and follow-up weights [25], including
the need to define operative weight as the weight at ad-
mission or just before surgery. Our data was based upon
weights obtained the day of admission based upon the
clinic code used for admitting patients for RYGB sur-
gery. Our length of follow-up was also above the recom-
mended minimum rate of 61%.
Conclusions
EHR data can be a valuable source of data for obesity re-
search, although the availability and integrity of different
data types can vary substantially. Access to a data ware-
house can greatly enhance the efficiency of data collec-
tion over direct extraction from the EHR. EHR derived
data can be used for a variety of research and clinical
uses such as for determining length of follow-up.
Additional files
Additional file 1: Supplementary materials.
Competing interest
Co-author Christopher Still receives grant and consulting support from
Ethicon-Endosurgery. Co-author Anthony Petrick receives educational grants
from Covidien and Ethicon-Endosurgery. Other authors declare no conflict of
interest.
Authors’ contributions
GCW, GSG, PB, GA, and CDS designed the study, directed the data analysis,
performed data analysis, and contributed to writing the paper. XC, CM, and
JS prepared the data set for analysis. WS, AP, JG, and DC directed the data
analysis and contributed to writing the paper. All of the authors have read
and approved the final manuscript.
Acknowledgements
This work was supported by funds from Geisinger Clinic, the Weis Center for
Research, the Geisinger Obesity Research Institute, and grants DK072488
(GSG), DK088231 (GSG), and DK091601 (GSG) from the NIH. We thank H.
Lester Kirchner for a careful reading of the manuscript.
We gratefully acknowledge the extraordinary cooperation and support of the
patients enrolled in the Geisinger Bariatric surgery program without which
these studies would not have been possible.
Author details
1Geisinger Obesity Research Institute, Geisinger Clinic, Danville, PA 17822,
USA. 2Center for Health Research, Danville, PA 17822, USA. 3Weis Center for
Research, Geisinger Clinic, Danville, PA 17822, USA. 4Department of Surgery,
Geisinger Medical Center, Danville, PA 17822, USA. 5Department of Surgery,
St. Francis Medical Center, Trenton, NJ, USA.
Received: 27 July 2011 Accepted: 18 April 2012
Published: 28 May 2012
References
1. Flegal K, Carroll M, Ogden C, Johnson C: Prevalence and trends in obesity
among US adults. JAMA 2002, 288:1723–1727.
2. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of
obesity. Gastroenterology 2007, 132(6):2087–2102.3. Mirabelli D, Chiusolo M, Ferrante D, Balzola F, Merletti F, Petroni ML: Long-
term mortality in a cohort of severely obese persons in Italy. Obesity
Silver (Spring, Md 2008, 16(8):1920–1925.
4. Sturm R: Increases in morbid obesity in the USA: 2000–2005. Public health
2007, 121(7):492–496.
5. Pi-Sunyer FX: How effective are lifestyle changes in the prevention of
type 2 diabetes mellitus? Nutr Rev 2007, 65(3):101–110.
6. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ,
Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, et al: Meta-analysis:
surgical treatment of obesity. Ann Intern Med 2005, 142(7):547–559.
7. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto
J, Bailey M, Anderson M: Adjustable gastric banding and conventional
therapy for type 2 diabetes: a randomized controlled trial. Jama 2008,
299(3):316–323.
8. Elder KA, Wolfe BM: Bariatric surgery: a review of procedures and
outcomes. Gastroenterology 2007, 132(6):2253–2271.
9. Lanyon RI, Maxwell BM: Predictors of outcome after gastric bypass
surgery. Obes Surg 2007, 17(3):321–328.
10. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J: An inventory for
measuring depression. Arch Gen Psychiatry 1961, 4:561–571.
11. Shields C, Franks P, Harp J, McDaniel S, Campbell T: Development of the
family emotional involement and critcism scale (feics): a self-report scale
to measure expressed emotion. J Marital Fam Ther 1992, 18(4):395–407.
12. Kolotkin RL, Crosby RD, Kosloski KD, Williams GR: Development of a brief
measure to assess quality of life in obesity. Obes Res 2001, 9(2):102–111.
13. Brownell K: The LEARN Program for Weight Control. 7th edition. Dallas, TX:
American Health Publishing Company; 1998.
14. Hays R, Stewart A (Eds): Measuring functioning and well being: the Medical
Outcomes Study approach. Durham, NC: Duke University Press; 1992.
15. Lerner D, Amick BC 3rd, Rogers WH, Malspeis S, Bungay K, Cynn D: The
Work Limitations Questionnaire. Med Care 2001, 39(1):72–85.
16. Celio AA, Wilfley DE, Crow SJ, Mitchell J, Walsh BT: A comparison of the
binge eating scale, questionnaire for eating and weight patterns-revised,
and eating disorder examination questionnaire with instructions with
the eating disorder examination in the assessment of binge eating
disorder and its symptoms. Int J Eat Disord 2004, 36(4):434–444.
17. Still CD, Wood GC, Chu X, Erdman R, Manney CH, Benotti PN, Petrick AT,
Strodel WE, Mirshahi UL, Mirshahi T, et al: High Allelic Burden of Four
Obesity SNPs Is Associated With Poorer Weight Loss Outcomes
Following Gastric Bypass Surgery. Obesity (Silver Spring) 2011, 19(8):1676–
1683.
18. Dallal RM, Quebbemann BB, Hunt LH, Braitman LE: Analysis of weight loss
after bariatric surgery using mixed-effects linear modeling. Obes Surg
2009, 19(6):732–737.
19. Stewart WF, Shah NR, Selna MJ, Paulus RA, Walker JM: Bridging the
inferential gap: the electronic health record and clinical evidence. Health
Aff (Millwood) 2007, 26(2):w181–w191.
20. Noel PH, Copeland LA, Pugh MJ, Kahwati L, Tsevat J, Nelson K, Wang CP,
Bollinger MJ, Hazuda HP: Obesity diagnosis and care practices in the
Veterans Health Administration. J Gen Intern Med 2010, 25(6):510–516.
21. Uzuner O: Second i2b2 workshop on natural language processing
challenges for clinical records. AMIA Annu Symp Proc 2008, 6:1252–1253.
22. Mishra NK, Cummo DM, Arnzen JJ, Bonander J: A rule-based approach for
identifying obesity and its comorbidities in medical discharge
summaries. J Am Med Inform Assoc 2009, 16(4):576–579.
23. Uzuner O: Recognizing obesity and comorbidities in sparse data. J Am
Med Inform Assoc 2009, 16(4):561–570.
24. Noel PH, Copeland LA, Perrin RA, Lancaster AE, Pugh MJ, Wang CP,
Bollinger MJ, Hazuda HP: VHA Corporate Data Warehouse height and
weight data: opportunities and challenges for health services research. J
Rehabil Res Dev 2010, 47(8):739–750.
25. Oria HE, Carrasquilla C, Cunningham P, Hess DS, Johnell P, Kligman MD,
Moorehead MK, Papadia FS, Renquist KE, Rosenthal R, et al: Guidelines for
weight calculations and follow-up in bariatric surgery. Surg Obes Relat Dis
2005, 1(1):67–68.
doi:10.1186/1472-6947-12-45
Cite this article as: Wood et al.: An electronic health record-enabled
obesity database. BMC Medical Informatics and Decision Making 2012
12:45.
